149 related articles for article (PubMed ID: 38218826)
1. Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway.
Lin HH; Zeng WH; Yang HK; Huang LS; Pan R; Lei NX
BMC Womens Health; 2024 Jan; 24(1):41. PubMed ID: 38218826
[TBL] [Abstract][Full Text] [Related]
2. FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value.
Zheng C; Ren Z; Chen H; Yuan X; Suye S; Yin H; Zhou Z; Fu C
Exp Cell Res; 2022 Dec; 421(2):113388. PubMed ID: 36257352
[TBL] [Abstract][Full Text] [Related]
3. Lipid Peroxidation, GSH Depletion, and
Sun L; Dong H; Zhang W; Wang N; Ni N; Bai X; Liu N
DNA Cell Biol; 2021 Feb; 40(2):172-183. PubMed ID: 33351681
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin Inhibits Endometrial Cancer Malignant Behaviors by Suppressing RAS/Mitogen-Activated Protein Kinase (MAPK) Pathway-Mediated Reactive Oxygen Species (ROS) and Ferroptosis.
Zhou D; Wu Q; Qiu H; Li M; Ji Y
Evid Based Complement Alternat Med; 2022; 2022():6177477. PubMed ID: 36276874
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis inhibitor ferrostatin‑1 alleviates homocysteine‑induced ovarian granulosa cell injury by regulating TET activity and DNA methylation.
Shi Q; Liu R; Chen L
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169856
[TBL] [Abstract][Full Text] [Related]
6. Ferrostatin-1 alleviates cytotoxicity of cobalt nanoparticles by inhibiting ferroptosis.
Zhang W; Wang C; Zhu W; Liu F; Liu Y
Bioengineered; 2022 Mar; 13(3):6163-6172. PubMed ID: 35200065
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of FXN overexpression on ferroptosis in L-Glu-induced SH-SY5Y cells.
Wang M; Xuan T; Li H; An J; Hao T; Cheng J
Acta Histochem; 2024 Jan; 126(1):152135. PubMed ID: 38266318
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-XIST Promotes Lung Adenocarcinoma Growth and Inhibits Ferroptosis by Regulating GPX4.
Lu CL; Liu J; Yang JF
Mol Biotechnol; 2023 Dec; ():. PubMed ID: 38153663
[TBL] [Abstract][Full Text] [Related]
9. GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.
Wei S; Yu Z; Shi R; An L; Zhang Q; Zhang Q; Zhang T; Zhang J; Wang H
BMC Cancer; 2022 Aug; 22(1):881. PubMed ID: 35962333
[TBL] [Abstract][Full Text] [Related]
10. Ferrostatin-1 alleviates angiotensin II (Ang II)- induced inflammation and ferroptosis in astrocytes.
Li S; Zhou C; Zhu Y; Chao Z; Sheng Z; Zhang Y; Zhao Y
Int Immunopharmacol; 2021 Jan; 90():107179. PubMed ID: 33278745
[TBL] [Abstract][Full Text] [Related]
11. Ferrostatin‑1 alleviates oxalate‑induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis.
Xie J; Ye Z; Li L; Xia Y; Yuan R; Ruan Y; Zhou X
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35703358
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p/3p in hepatocellular carcinoma.
Zhou L; Zhang Q; Cheng J; Shen X; Li J; Chen M; Zhou C; Zhou J
Drug Discov Ther; 2023 Sep; 17(4):248-256. PubMed ID: 37599085
[TBL] [Abstract][Full Text] [Related]
13. The humanin analogue (HNG) alleviates intrauterine adhesions by inhibiting endometrial epithelial cells ferroptosis: a rat model-based study.
Zou L; Huang J; Zhang Q; Mo H; Xia W; Zhu C; Rao M
Hum Reprod; 2023 Dec; 38(12):2422-2432. PubMed ID: 37814907
[TBL] [Abstract][Full Text] [Related]
14. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
15. FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma.
Li X; Liu J
BMC Cancer; 2023 Feb; 23(1):179. PubMed ID: 36814203
[TBL] [Abstract][Full Text] [Related]
16. Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells.
Ding J; Li M; Deng L; Li T
Biomed Res Int; 2018; 2018():8372085. PubMed ID: 30175145
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
18. Abnormally Expressed Ferroptosis-Associated FANCD2 in Mediating the Temozolomide Resistance and Immune Response in Glioblastoma.
Song L; Wu J; Fu H; Wu C; Tong X; Zhang M
Front Pharmacol; 2022; 13():921963. PubMed ID: 35754466
[TBL] [Abstract][Full Text] [Related]
19. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
20. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis.
Liu P; Feng Y; Li H; Chen X; Wang G; Xu S; Li Y; Zhao L
Cell Mol Biol Lett; 2020; 25():10. PubMed ID: 32161620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
